MolMed S.p.A. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 34 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

MolMed S.p.A. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'MolMed S.p.A. - Product Pipeline Review - 2014', provides an overview of the MolMed S.p.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of MolMed S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of MolMed S.p.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of MolMed S.p.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the MolMed S.p.A.'s pipeline products

Reasons to buy

- Evaluate MolMed S.p.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of MolMed S.p.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the MolMed S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of MolMed S.p.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of MolMed S.p.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of MolMed S.p.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
MolMed S.p.A. Snapshot 5
MolMed S.p.A. Overview 5
Key Information 5
Key Facts 5
MolMed S.p.A. - Research and Development Overview 6
Key Therapeutic Areas 6
MolMed S.p.A. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
MolMed S.p.A. - Pipeline Products Glance 10
MolMed S.p.A. - Late Stage Pipeline Products 10
Pre-Registration Products/Combination Treatment Modalities 10
Phase III Products/Combination Treatment Modalities 11
MolMed S.p.A. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
MolMed S.p.A. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
MolMed S.p.A. - Drug Profiles 15
HSV-TK 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
NGR-hTNF 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
NGR-IFN Gamma 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
MolMed S.p.A. - Pipeline Analysis 21
MolMed S.p.A. - Pipeline Products by Target 21
MolMed S.p.A. - Pipeline Products by Route of Administration 22
MolMed S.p.A. - Pipeline Products by Molecule Type 23
MolMed S.p.A. - Pipeline Products by Mechanism of Action 24
MolMed S.p.A. - Recent Pipeline Updates 25
MolMed S.p.A. - Dormant Projects 30
MolMed S.p.A. - Discontinued Pipeline Products 31
Discontinued Pipeline Product Profiles 31
HSV-TK 31
MolMed S.p.A. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 34
Disclaimer 34

List of Tables
MolMed S.p.A., Key Information 5
MolMed S.p.A., Key Facts 5
MolMed S.p.A. - Pipeline by Indication, 2014 7
MolMed S.p.A. - Pipeline by Stage of Development, 2014 8
MolMed S.p.A. - Monotherapy Products in Pipeline, 2014 9
MolMed S.p.A. - Pre-Registration, 2014 10
MolMed S.p.A. - Phase III, 2014 11
MolMed S.p.A. - Phase II, 2014 12
MolMed S.p.A. - Phase I, 2014 13
MolMed S.p.A. - Preclinical, 2014 14
MolMed S.p.A. - Pipeline by Target, 2014 21
MolMed S.p.A. - Pipeline by Route of Administration, 2014 22
MolMed S.p.A. - Pipeline by Molecule Type, 2014 23
MolMed S.p.A. - Pipeline Products by Mechanism of Action, 2014 24
MolMed S.p.A. - Recent Pipeline Updates, 2014 25
MolMed S.p.A. - Dormant Developmental Projects,2014 30
MolMed S.p.A. - Discontinued Pipeline Products, 2014 31
MolMed S.p.A., Other Locations 32